Step into summer in the best shape of your life with these reports from Harvard Medical School.
Learn How

Start your exercise and fitness program and reap the benefits of being more fit, stronger and healthier!

Warmer weather is on the way and it's not too late to get in shape for the summer. These 3 reports can help you enjoy outdoor activities in the best shape of your life:

References for "Encouraging patients to take medication as prescribed"

JAN 2010

Did you know?

You can get instant online access to all of the articles from the January 2010 issue of Harvard Mental Health Letter for only $5.

Already a subscriber? Login for complete instant access.

If you want a button/link to remove the box (not sure if you do or not...), it would look like this: Cancel

Byerly MJ, et al. “Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia,” Psychiatric Services (June 2007): Vol. 58, No. 6, pp. 844–47. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17535946

Dolder CR, et al. “Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?” American Journal of Psychiatry (Jan. 2002): Vol. 159, No. 1, pp. 103–08. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11772697

Gilmer TP, et al. “Adherence to Treatment with Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries with Schizophrenia,” American Journal of Psychiatry (April 2004): Vol. 161, No. 4, pp. 692–99. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15056516

Ho PM, et al. “Medication Adherence: Its Importance in Cardiovascular Outcomes,” Circulation (June 16, 2009): Vol. 119, No. 23, pp. 3028–35.

Julius RJ, et al. “Medication Adherence: A Review of the Literature and Implications for Clinical Practice,” Journal of Psychiatric Practice (Jan. 2009): Vol. 15, No. 1, pp. 34–44. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19182563

Kothawaia P, et al. “Systemic Review and Meta-Analysis of Real-World Adherence to Drug Therapy for Osteoporosis,” Mayo Clinic Proceedings (Dec. 2007): Vol. 82, No. 12, pp. 1493–501.

Lacro JP, et al. “Prevalence of and Risk Factors for Medication Nonadherence in Patients with Schizophrenia: A Comprehensive Review of Recent Literature,” Journal of Clinical Psychiatry (Oct. 2002): Vol. 63, No. 10, pp. 892–909. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12416599

Svarstad BL, et al. “Using Drug Claims Data to Assess the Relationship of Medication Adherence with Hospitalization and Costs,” Psychiatric Services (June 2001): Vol. 52, No. 6, pp. 805–11. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11376229

Valenstein M, et al. “Pharmacy Data Identify Poorly Adherent Patients with Schizophrenia at Increased Risk for Admission,” Medical Care (Aug. 2002): Vol. 40, No. 8, pp. 630–09. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12187177

Velligan DI, et al. “The Expert Consensus Guideline Series: Adherence Problems in Patients with Serious and Persistent Mental Illness,” Journal of Clinical Psychiatry (2009): Vol. 70, Suppl. 4, pp. 1–46; quiz 7–8. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19686636